US Park Service Investigates Mystery Illness Among Grand Canyon Rafters
A cluster of unexplained flu-like illnesses among Colorado River rafters has triggered a federal health investigation, raising concerns for the US outdoor tourism sector and public health monitoring.
The US National Park Service has launched an investigation into a mystery illness affecting at least a dozen individuals who recently completed rafting trips on the Colorado River. Patients are reporting severe, flu-like symptoms that have resulted in hospitalizations and extensive, inconclusive medical testing.
Matthew Wappett, a 53-year-old professor at Utah State University, represents the earliest known case of this cluster. After finishing a 16-day, 225-mile expedition from Lee’s Ferry to Diamond Creek, he developed severe symptoms. He noted that he initially thought he had "post-trip blues" before an emergency room doctor informed him he was "part of a Grand Canyon mystery."
Urgent care physicians immediately referred him to an emergency room, where he received intravenous treatments and a course of antibiotics. Medical teams have screened him for a wide array of pathogens, including Lyme disease, Hantavirus, West Nile virus, and Leptospirosis, but all results remain inconclusive.
The scope of the issue became apparent when Wappett discovered online forums where other Grand Canyon rafters described identical health struggles. Every known affected individual disembarked from the river after his group, suggesting a shared environmental exposure during the late spring season.
For the global outdoor tourism market, such unexplained health clusters present a tangible reputational and operational risk. The Grand Canyon generates significant revenue from international visitors, and prolonged uncertainty surrounding visitor safety could impact booking trends for commercial outfitters and independent expeditions alike.
Public health officials are now actively seeking data from anyone who undertook a Grand Canyon river trip in 2026 and experienced similar symptoms. The agency has directed affected individuals to contact the National Park Service Office of Health and Safety to aid the ongoing epidemiological traceback.
Wappett recently began a regimen of the antibiotic doxycycline, reporting dramatic improvement in his symptoms after four days, though joint aches persist. His gradual recovery offers a tentative positive signal, even as the broader medical community awaits definitive answers regarding the pathogen's origin.
